By Conor Coyle
Date: Wednesday 02 Aug 2017
(ShareCast News) - Hikma Pharmaceuticals: Morgan Stanley downgrades to Equal Weight with a target price of 1600p.
No recent information was found.
Currency | US Dollars |
Share Price | $ 0.00 |
Closing Price Change | $ 0.00 |
% Change | 0.00 % |
52 Week High | $0.00 |
52 Week Low | $0.00 |
Volume | 0 |
Shares Issued | 2.44m |
RiskGrade | 88 |
You are here: research